tradingkey.logo

Evotec SE

EVO
3.130USD
-0.010-0.32%
收盘 12/24, 13:00美东报价延迟15分钟
1.11B总市值
亏损市盈率 TTM

Evotec SE

3.130
-0.010-0.32%

关于 Evotec SE 公司

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

Evotec SE简介

公司代码EVO
公司名称Evotec SE
上市日期Oct 11, 1999
CEOWojczewski (Christian)
员工数量4827
证券类型Depository Receipt
年结日Oct 11
公司地址Essener Bogen 7
城市HAMBURG
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Germany
邮编22419
电话4940560810
网址https://www.evotec.com/
公司代码EVO
上市日期Oct 11, 1999
CEOWojczewski (Christian)

Evotec SE公司高管

名称
名称/职务
职务
持股
持股变动
Prof. Dr. Iris Loewfriedrich
Prof. Dr. Iris Loewfriedrich
Independent Chairwoman of the Supervisory Board
Independent Chairwoman of the Supervisory Board
--
--
Mr. Volker Braun
Mr. Volker Braun
Senior Vice President, Head of Global Investor Relations and ESG
Senior Vice President, Head of Global Investor Relations and ESG
--
--
Mr. Wesley Wheeler
Mr. Wesley Wheeler
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Dr. Christian Wojczewski
Dr. Christian Wojczewski
Chief Executive Officer, Member of the Management Board
Chief Executive Officer, Member of the Management Board
--
--
Dr. Duncan Mchale
Dr. Duncan Mchale
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Ms. Camilla Macapili Languille
Ms. Camilla Macapili Languille
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Constanze Ulmer-Eilfort
Dr. Constanze Ulmer-Eilfort
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mrs. Aurelie Dalbiez
Mrs. Aurelie Dalbiez
Chief People Officer, Member of the Management Board
Chief People Officer, Member of the Management Board
--
--
Dr. Cord Dohrmann, Ph.D.
Dr. Cord Dohrmann, Ph.D.
Chief Scientific Officer, Member of the Management Board
Chief Scientific Officer, Member of the Management Board
--
--
Ms. Laetitia Rouxel
Ms. Laetitia Rouxel
Chief Financial Officer, Member of the Management Board
Chief Financial Officer, Member of the Management Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Prof. Dr. Iris Loewfriedrich
Prof. Dr. Iris Loewfriedrich
Independent Chairwoman of the Supervisory Board
Independent Chairwoman of the Supervisory Board
--
--
Mr. Volker Braun
Mr. Volker Braun
Senior Vice President, Head of Global Investor Relations and ESG
Senior Vice President, Head of Global Investor Relations and ESG
--
--
Mr. Wesley Wheeler
Mr. Wesley Wheeler
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Dr. Christian Wojczewski
Dr. Christian Wojczewski
Chief Executive Officer, Member of the Management Board
Chief Executive Officer, Member of the Management Board
--
--
Dr. Duncan Mchale
Dr. Duncan Mchale
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Ms. Camilla Macapili Languille
Ms. Camilla Macapili Languille
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2024
FY2023
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
United States
482.23M
55.94%
Switzerland
117.94M
13.68%
United Kingdom
100.06M
11.61%
Rest of the world
89.00M
10.32%
Germany
35.59M
4.13%
其他
37.16M
4.31%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 11月16日 周日
更新时间: 11月16日 周日
持股股东
股东类型
持股股东
持股股东
占比
Mubadala Investment Company PJSC
1.29%
Wellington Management Company, LLP
0.40%
BlackRock Institutional Trust Company, N.A.
0.36%
DCF Advisers, LLC
0.34%
WCM Investment Management
0.08%
其他
97.52%
持股股东
持股股东
占比
Mubadala Investment Company PJSC
1.29%
Wellington Management Company, LLP
0.40%
BlackRock Institutional Trust Company, N.A.
0.36%
DCF Advisers, LLC
0.34%
WCM Investment Management
0.08%
其他
97.52%
股东类型
持股股东
占比
Sovereign Wealth Fund
1.29%
Investment Advisor
0.94%
Investment Advisor/Hedge Fund
0.42%
Family Office
0.05%
Hedge Fund
0.04%
Research Firm
0.01%
其他
97.24%

机构持股

更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
76
9.39M
2.97%
--
2025Q3
77
9.39M
2.97%
-16.64K
2025Q2
74
9.40M
2.85%
+334.04K
2025Q1
60
9.08M
2.82%
-923.30K
2024Q4
59
8.93M
2.90%
+634.42K
2024Q3
56
8.37M
3.36%
+770.57K
2024Q2
55
7.62M
2.73%
+2.19M
2024Q1
54
5.00M
2.98%
-5.56M
2023Q4
57
5.71M
1.76%
+4.47M
2023Q3
51
1.23M
1.80%
-162.10K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Mubadala Investment Company PJSC
4.60M
1.29%
--
--
Jun 30, 2025
Wellington Management Company, LLP
1.21M
0.34%
-697.85K
-36.66%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
1.32M
0.37%
-184.93K
-12.32%
Jun 30, 2025
DCF Advisers, LLC
1.11M
0.31%
+362.91K
+48.29%
Jun 30, 2025
WCM Investment Management
297.91K
0.08%
+297.91K
--
Jun 30, 2025
Parametric Portfolio Associates LLC
303.50K
0.09%
+303.50K
--
Jun 30, 2025
Pitcairn
261.18K
0.07%
+261.18K
--
Jun 30, 2025
Citadel Advisors LLC
33.57K
0.01%
+33.57K
--
Jun 30, 2025
LPL Financial LLC
37.84K
0.01%
+37.84K
--
Jun 30, 2025
Envestnet Asset Management, Inc.
91.66K
0.03%
+91.66K
--
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Biotechnology ETF
0.08%
ActivePassive International Equity ETF
0%
DFA Dimensional Intl Sustainability Core 1 ETF
0%
iShares Biotechnology ETF
占比0.08%
ActivePassive International Equity ETF
占比0%
DFA Dimensional Intl Sustainability Core 1 ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Evotec SE的前五大股东是谁?

Evotec SE 的前五大股东如下:
Mubadala Investment Company PJSC持有股份:4.60M,占总股份比例:1.29%。
Wellington Management Company, LLP持有股份:1.21M,占总股份比例:0.34%。
BlackRock Institutional Trust Company, N.A.持有股份:1.32M,占总股份比例:0.37%。
DCF Advisers, LLC持有股份:1.11M,占总股份比例:0.31%。
WCM Investment Management持有股份:297.91K,占总股份比例:0.08%。

Evotec SE的前三大股东类型是什么?

Evotec SE 的前三大股东类型分别是:
Mubadala Investment Company PJSC
Wellington Management Company, LLP
BlackRock Institutional Trust Company, N.A.

有多少机构持有Evotec SE(EVO)的股份?

截至2025Q4,共有76家机构持有Evotec SE的股份,合计持有的股份价值约为9.39M,占公司总股份的2.97%。与2025Q3相比,机构持股有所增加,增幅为-0.00%。

哪个业务部门对Evotec SE的收入贡献最大?

在FY2024,--业务部门对Evotec SE的收入贡献最大,创收--,占总收入的--%。
KeyAI